048410.KQ

Hyundai Bioscience Co., Ltd. [048410.KQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

048410.KQ Stock Summary

Top 10 Correlated ETFs

048410.KQ

Top 10 Correlated Stocks

048410.KQ

In the News

048410.KQ Financial details

Company Rating
-
Market Cap
791.59B
Income
-14.5B
Revenue
9.48B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
63
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-52.97
Forward P/E
-
PEG
57.28
P/S
92.98
P/B
17.43
P/C
-
P/FCF
-85.33
Quick Ratio
2.17
Current Ratio
2.59
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-364.4
EPS next Y
-
EPS next Q
-
EPS this Y
-9.21%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-20.62%
Revenue Q/Q
-42.25%
EPS Q/Q
308.55%
-
-
-
-
SMA20
-0.06%
SMA50
-17.11%
SMA100
-16.81%
Inst Own
-
Inst Trans
-
ROA
-29%
ROE
-31%
ROC
-0.32%
Gross Margin
53%
Oper. Margin
-170%
Profit Margin
-175%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
17600.0-41200.0
52W High
-73.91%
52W Low
-38.92%
RSI
42.58
Rel Volume
0.32
Avg Volume
466.01K
Volume
147.07K
Perf Week
-4.19%
Perf Month
-9.44%
Perf Quarter
-37.5%
Perf Half Y
-37.46%
-
-
-
-
Beta
1.171
-
-
Volatility
245.67%, 544.19%
Prev Close
-2.63%
Price
10750
Change
-2.54%

Something similar

Top by Market Cap
0YXG.L
VTSAX
DHR-PB
M&M.NS
ABEC.DE
Top Correlated ETFs
352540.KS
232080.KS
304770.KS
229200.KS
270810.KS
Top Correlated Stocks
003670.KS
047050.KS
046890.KQ
128940.KS
008930.KS
Similar Market Cap
NHPC.NS
AKRN.ME
5201.T
6448.T
KCHOL.IS

Company Profile

Healthcare Medical - Pharmaceuticals

Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.